Therapy Areas: Oncology
Epredia signs EU distribution deal with Mindpeak for AI pathology software
24 February 2026 - Precision cancer diagnostics specialist Epredia, a subsidiary of PHC Holdings Corporation (TSE:6523), and Mindpeak, a provider of AI solutions for clinical and research pathology, o...
Astellas Pharma signs global strategic collaboration with Vir Biotechnology
24 February 2026 - Japanese pharmaceutical company Astellas Pharma Inc announced on Monday that it has formed a global strategic collaboration with Vir Biotechnology Inc (Nasdaq:VIR), a US-based, clin...
Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale
23 February 2026 - Illumina Inc (NASDAQ: ILMN), a provider of DNA sequencing and array-based technologies, announced on Monday that it has launched an 18-month innovation roadmap for its NovaSeq X pla...
Gilead to acquire Arcellx to gain full control of anito-cel
23 February 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Monday that it has agreed to acquire Arcellx (NASDAQ:ACLX) for USD115 per share in cash plus a USD5 continge...
AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL
23 February 2026 - US pharmaceutical company AbbVie (NYSE:ABBV) announced on Friday that the US Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for the com...
CStone Pharmaceuticals' sugemalimab granted new indication by UK MHRA
23 February 2026 - Chinese biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) announced on Sunday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new ind...